Skip to main content
Clinical Trials/NCT04345536
NCT04345536
Completed
Not Applicable

Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital

Oslo University Hospital1 site in 1 country2,519 target enrollmentMarch 15, 2020
ConditionsCOVID-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Oslo University Hospital
Enrollment
2519
Locations
1
Primary Endpoint
Mortality
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Covid-19 is a recently emerging infectious disease with a very large impact on health care world-wide. The disease is still poorly described. It is an urgent need for better clinical characteristics. A prospective, quality register is therefore established for increasing the knowledge about the disease, the covid patients and the prognosis.

Detailed Description

All patient hospitalized at Oslo University Hospital, Ullevål, is prospectively registered in the approved quality register. Background, clinical and paraclinical data is harvested and registered, as well as treatment and mortality.

Registry
clinicaltrials.gov
Start Date
March 15, 2020
End Date
November 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Aleksander Rygh Holten

MD

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Confirmed covid-19
  • hospitalized

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Mortality

Time Frame: 3 month

Mortality in hospitalized covid patients

Severe disease

Time Frame: 2 weeks

Number of patients with severe disease

Study Sites (1)

Loading locations...

Similar Trials